Synthelis Biotech Overview
- Year Founded
-
2011
- Status
-
Acquired/Merged
- Employees
-
8
- Latest Deal Type
-
Later Stage VC
- (Cancelled)
- Investors
-
1
Synthelis Biotech General Information
Description
Developer of protein targets designed to assist the development of vaccines, biologics, enzymes, engineered proteins, diagnostic tools, and high-throughput molecule or ligand screening. The company's proprietary cell-free expression technology opens new socio-economic horizons for the development and production of innovative health products by designing biomolecules for pharmaceutical, biomedical, and biotechnological research organizations and academic laboratories, enabling medicine developers to assist with structural and functional/electrophysiological studies.
Contact Information
Website
www.synthelis.com(Operating Subsidiary)
Corporate Office
- 5, Avenue du Grand Sablon
- La Tronche
- 38700 Grenoble
- France
Corporate Office
- 5, Avenue du Grand Sablon
- La Tronche
- 38700 Grenoble
- France
Synthelis Biotech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC | Cancelled | Generating Revenue | ||||
| 6. Angel (individual) | 01-Jan-2024 | Completed | Generating Revenue | |||
| 5. Grant | 01-Jan-2024 | Completed | Generating Revenue | |||
| 4. Merger/Acquisition | 24-Nov-2023 | Completed | Generating Revenue | |||
| 3. Later Stage VC | 23-Jun-2016 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 21-Jan-2014 | $942K | $942K | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | 10-Jan-2011 | Completed | Generating Revenue |
Synthelis Biotech Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| P | ||||||||
| P | ||||||||
| O | 14,579 | $1.125645 |
Synthelis Biotech Comparisons
Industry
Financing
Details
Synthelis Biotech Competitors (3)
One of Synthelis Biotech’s 3 competitors is Daicel Arbor Biosciences, a Formerly Accelerator/Incubator backed company based in Ann Arbor, MI.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Daicel Arbor Biosciences | Formerly Accelerator/Incubator backed | Ann Arbor, MI | ||||
| Cube Biotech | Private Equity-Backed | Monheim, Germany | ||||
| Vaxcyte | Formerly VC-backed | San Carlos, CA |
Synthelis Biotech Patents
Synthelis Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20100189774-A1 | Formation of proteoliposomes containing membrane proteins by means of an acellular protein synthesis system | Active | 26-Apr-2007 | ||
| US-9206456-B2 | Formation of proteoliposomes containing membrane proteins by means of an acellular protein synthesis system | Active | 26-Apr-2007 |
Synthelis Biotech Signals
Synthelis Biotech Former Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Alpes Capital Innovation | Venture Capital | Minority | ||
| Banque Populaire Auvergne Rhône Alpes | Corporation | Minority | ||
| Celertis Finance | Corporation | Minority | ||
| Crédit Agricole Alpes Développement | PE/Buyout | Minority | ||
| Crédit Agricole Sud Rhône Alpes | Lender/Debt Provider | Minority |
Synthelis Biotech FAQs
-
When was Synthelis Biotech founded?
Synthelis Biotech was founded in 2011.
-
Where is Synthelis Biotech headquartered?
Synthelis Biotech is headquartered in Grenoble, France.
-
What is the size of Synthelis Biotech?
Synthelis Biotech has 8 total employees.
-
What industry is Synthelis Biotech in?
Synthelis Biotech’s primary industry is Pharmaceuticals.
-
Is Synthelis Biotech a private or public company?
Synthelis Biotech is a Private company.
-
What is Synthelis Biotech’s current revenue?
The current revenue for Synthelis Biotech is .
-
How much funding has Synthelis Biotech raised over time?
Synthelis Biotech has raised $469K.
-
Who are Synthelis Biotech’s investors?
Alpes Capital Innovation, Banque Populaire Auvergne Rhône Alpes, Celertis Finance, Crédit Agricole Alpes Développement, and Crédit Agricole Sud Rhône Alpes are 5 of 13 investors who have invested in Synthelis Biotech.
-
Who are Synthelis Biotech’s competitors?
Daicel Arbor Biosciences, Cube Biotech, and Vaxcyte are competitors of Synthelis Biotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process